Abstract
Chagas disease (CD) is a chronic and endemic illness caused by the parasite Trypanosoma cruzi. Microvascular disturbances play an important role in the progress of the disease. The purinergic signaling system participates in regulatory functions, such as immunomodulation, neuroprotection, and thromboregulation. This study aimed to investigate the activities of purinergic system ecto-enzymes present on the platelet surface and the platelet aggregation profile from patients with indeterminate form of Chagas disease (IFCD). Thirty patients diagnosed with IFCD and 30 healthy subjects were selected. Ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase), ecto-nucleotide pyrophosphatase/phosphodiesterase (E-NPP), ecto-5′-nucleotidase (E-5′-NT) and ecto-adenosine deaminase (E-ADA) activities were measured in platelets isolated from these individuals as well as the platelet aggregation. Results demonstrated an increase of 21 % in the E-NPP activity and 30 % in the E-5′-NT activity in IFCD group (P < 0.05); however, a decrease of 34 % in the E-ADA activity was determined in the same group (P < 0.001). A significant decrease of 12.7 % and 12.8 % in the platelet aggregation of IFCD group in two different concentrations of ADP (5 and 10 μM) was observed, respectively (P < 0.05). Increased E-NPP and E-5-NT activities as well as decreased E-ADA activity in platelets of patients with IFCD contributed to decrease platelet aggregation, suggesting that the purinergic system is involved in the thromboregulation process in these patients, since adenosine (the final product of ATP hydrolysis) has cardioprotective and vasodilator effects that prevent the clinical progress of the disease.
Similar content being viewed by others
References
Rossi MA, Bestetti RB (1995) Hipótese unificada sobre a patogênese da cardiopatia chagásica crônica. Implicações terapêuticas. Arq Bras Cardiol 64:255–260
Prata A (2001) Clinical and epidemiological aspects of Chagas' disease. Lancet Infect Dis 1:92–100
Prata A (1959) Prognóstico e complicações da doença de Chagas. Rev Goiana Med 5:87–96
Gonçalves JG, Dias Silva VJ, Calzada Borges MC, Prata A, Correia D (2010) Mortality indicators among chronic Chagas patients living in an endemic area. Int J Cardiol 143:235–242
Rossi MA (1990) Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am Heart J 120:233–236
Prata A (1994) Chagas' disease. Infect Dis Clin North Am 8:61–76
Jr Rassi A, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, Hasslocher-Moreno A, Sousa AS, Scanavacca MI (2006) Development and validation of a risk score for predicting death in Chagas' heart disease. N Engl J Med 355:799–808
Marcus AJ, Broekman MJ, Drosopoulos JH, Pinsky DJ, Islam N, Maliszewsk CR (2001) Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular disease. Ital Heart J 2:824–830
Birk AV, Broekman MJ, Gladek EM, Robertson HD, Drosopoulos JH, Marcus AJ, Szeto HH (2002) Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 140:166–175
Ralevic V, Burnstock G (2003) Involvement of purinergic signaling in cardiovascular diseases. Drug News Perspect 16:133–140
Atkinson B, Dwyer K, Enjyoji K, Robson SC (2006) Ecto-nucleotidases of the cd-39/ntpdase family modulated platelet activation on thrombous formation: potential as therapeutic targets. Blood Cells Mol Dis 36:217–222
Clifford EE, Parker K, Humphreys BD, Kertesy SB, Dubyak GR (1998) The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes. Blood 91:3172–3181
Léon C, Hechler B, Vial C, Leray C, Cazenave JP, Gachet C (1997) The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 403:26–30
Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D et al (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (Lond) 409:202–207
Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedeberg Arch Pharmacol 362:299–309
Yang D, Chen H, Koupenova M, Carroll SH, Eliades A, Freedman JE, Toselli P, Ravid K (2010) A new role for the A2b adenosine receptor in regulating platelet function. J Thromb Haemost 8:817–827
Johnston-Cox HA, Yang D, Ravid K (2011) Physiological implications of adenosine receptor-mediated platelet aggregation. J Cell Physiol 226:46–51
Pilla C, Emanuelli T, Frassetto SS, Battastini AMO, Dias RD, Sarkis JJF (1996) ATP diphosphohydrolase activity (Apyrase, EC 3.6.1.5.) in human blood platelets. Platelets 7:225–230
Lunkes IG, Lunkes D, Stefanello F, Morch A, Morch MV, Mazzantti MC, Schetinger MCR (2003) Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 109:189–194
Spanevello RM, Mazzanti CM, Bagatini M, Correa M, Schmatz R, Stefanello N, Thomé G, Morsch VM, Becker L, Bellé L, de Oliveira L, Schetinger MR (2010) Activities of the enzymes that hydrolyze adenine nucleotides in platelets from multiple sclerosis patients. J Neurol 257:24–30
Becker LV, Rosa CS, Souza VCG, Bagatini MD, Casali EA, Leal CA, da Silva JC, Moretto MB, de Pinheiro FV, Morsch VM, Schetinger MR, Leal DB (2010) Activities of enzymes that hydrolyze adenine nucleotides in platelets from patients with rheumatoid arthritis. Clin Biochem 43:1096–1100
Maldonado PA, Corrêa MC, Becker LV, Flores C, Moretto MB, Morsch V, Schetinger MRC (2008) Ectonucleotide pyrophosphatase/phosphodiesterase (E-NPP) and adenosine deaminase (ADA) activities in patients with uterine cervix neoplasia. Clin Biochem 41:400–406
Bagatini MD, Martins CC, Battisti V, Spanevello RM, Gasparetto D, Rosa CS, Gonçalves JF, Schetinger MR, dos Santos RB, Morsch VM (2008) Hydrolysis of adenine nucleotides in platelets from patients with acute myocardial infarction. Clin Biochem 41:1181–1185
Leal CA, Schetinger MR, Leal DB, Bauchspiess K, Schrekker CM, Maldonado PA, Morsch VM, da Silva JE (2007) NTPDase and 5′-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis. Mol Cell Biochem 304:325–330
Anonymous (1985) Meeting of applied research in Chagas disease. Validity of the concept of indeterminate form. Rev Soc Bras Med Trop 18:46
Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of proteins-dye binding. Anal Biochem 72:248–254
Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157:375–380
Fürsternau C, da Trentin DS, Barreto-Chaves ML, Sarkis JJ (2006) Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. Platelets 17:84–91
Sakura H, Nagashima S, Nakashima A, Maeda M (1998) Characterization of fetal serum 5′-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res 91:83–89
Frassetto SS, Dias RD, Sarkis JJ (1993) Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets. Mol Cell Biochem 129:47–55
Giusti G, Galanti B (1984) Colorimetric Method. In: Bergmeyer HU (ed) Methods of enzymatic analysis. Verlag Chemie, Weinheim, pp 315–323
Born GVR, Cross MJ (1963) The aggregation of blood platelets. J Physiol 95:168–178
Añez N, Carrasco H, Parada H, Crisante G, Rojas A, Fuenmayor C, Gonzalez N, Percoco G, Borges R, Guevara P, Ramirez JL (1999) Myocardial parasite persistence in chronic Chagasic patients. AmJTrop Med Hyg 60:726–732
Lopes ER, Chapadeiro E, Andrade ZA, Almeida H, Rocha A (1981) Pathological anatomy of hearts from asymptomatic Chagas disease patients dying in a violent manner. Mem Inst Oswald Cruz 76:189–197
Lopes ER, Rocha A, Adad SJ, Fernandes EL, Chapadeiro E (1988) Necroscopic study of a case of chronic form of Chagas disease with electrocardiogram and x-rays of normal thorax. Special reference to the excito-conductor system of the heart. Rev Soc Bras Med Trop 21:67–70
Cardoso JE, Brener Z (1980) Hematological changes in mice experimentally infected with Trypanosoma cruzi. Mem Inst Oswald Cruz 75:97–104
Jamra MA, De Freitas JL, Amato Neto V, Da Silva LH, Tartari JT (1954) Hematological aspects of the initial phases of Chagas' disease. Rev Paul Med 45:544–552
Rossi MA, Gonçalves S, Ribeiro-dos-Santos R (1984) Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis. Am J Pathol 114:209–216
Tanowitz HB, Burns ER, Sinha AK, Kahn NN, Morris SA, Factor SM, Hatcher VB, Bilezikian JP, Baum SG, Wittner M (1990) Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. AmJTrop Med Hyg 43:274–281
Gordon EL, Pearson JD, Dickinson ES, Moreau D, Slakey LL (1989) The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface. J Biol Chem 264:18986–18995
Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, D'Orléans-Juste P, Marceau F, Thorin E, Sévigny J (2010) NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc Res 85:204–213
Heine P, Braun N, Heilbronn A, Zimmermann H (1999) Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. Eur J Biochem 262:102–107
Soslau G, Youngprapakorn D (1997) A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta 1355:131–140
Park HS, Hourani SM (1999) Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adenosine 5-diphosphate (ADP) in human platelet. Br J Pharmacol 127:1359–1366
Borowiec A, Lechward K, Tkacz-Stachowska K, Skladanowski AC (2006) Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5′-nucleotidases. Acta Biochim Pol 53:269–278
Fretes RE, Paglini P, Fernández AR, Enders J, de Fabro SP (1999) Trypanosoma cruzi: increased 5′-nucleotidase activity associated with dysfunction of adrenergic receptors in acutely infected albino Swiss mice. J Parasitol 85:970–972
Zhai X, Zhou X, Ashraf M (1995) Interaction of singlet oxygen with 5′-nucleotidase in rat hearts. J Mol Cell Cardiol 27:2453–2464
Headrick JP, Emerson CS, Berr SS, Berne RM, Matherne GP (1996) Interstitial adenosine and cellular metabolism during beta-adrenergic stimulation of the in situ rabbit heart. Cardiovasc Res 31:699–710
Da Silva AS, Pimentel VC, Fiorenza AM, França RT, Tonin AA, Jaques JA, Leal CA, Da Silva CB, Morsch V, Sschetinger MR, Lopes ST, Monteiro SG (2011) Activity of cholinesterases and adenosine deaminase in blood and serum of rats experimentally infected with Trypanosoma cruzi. Ann Trop Med Parasitol 105:385–391
Tanowitz HB, Kirchhoff LV, Simon D, Morris SA, Weiss LM, Wittner M (1992) Chagas' disease. Clin Microbiol Rev 5:400–419
Paul S, Feoktistov I, Hollister AS, Robertson D, Biaggioni I (1990) Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase. Mol Pharmacol 37:870–875
Linden MD, Barnard MR, Frelinger AL, Michelson AD, Przyklenk K (2008) Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models. Thromb Res 121:689–698
Sim DS, Merrill-Skoloff G, Furie BC, Furie B, Flaumenhaft R (2004) Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood 103:2127–2134
Minamino T, Kitakaze M, Morioka T, Node K, Komamura K, Takeda H, Inoue M, Hori M, Kamada T (1996) Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity. Am J Physiol 270:H238–H244
Kitakaze M, Minamino T, Node K, Komamura K, Hori M (1996) Activation of ecto-5′-nucleotidase and cardioprotection by ischemic preconditioning. Basic Res Cardiol 91(1):23–26
Acknowledgements
This study was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and Fundo de Incentivo a Pesquisa (FIPE/UFSM), Brazil.
Disclosure of conflicts of interests
Author declares there are no actual or potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Souza, V.d.C.G., Schlemmer, K.B., Noal, C.B. et al. Purinergic system ecto-enzymes participate in the thromboregulation of patients with indeterminate form of Chagas disease. Purinergic Signalling 8, 753–762 (2012). https://doi.org/10.1007/s11302-012-9322-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-012-9322-7